Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. AUROBINDO PHARMA USA INC. (D.N.J. 2017)
✉ Email this page to a colleague
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. AUROBINDO PHARMA USA INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-10-04 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-11-12 |
| Cause | 15:1126 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Parties | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.; HETERO USA INC. | ||
| Patents | 8,426,586; 8,545,884; 9,539,258; RE43,431 | ||
| Attorneys | JEFFREY S. SOOS; SARAH ANN SULLIVAN | ||
| Firms | Cosner Cosner & Youngelson; Eric I. Abraham | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. AUROBINDO PHARMA USA INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. AUROBINDO PHARMA USA INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-10-04 | 1 | United States Patent No. 8,426,586. A true and correct copy of United States Patent No. 8,426,586 is attached… infringement of United States Patent No. 8,426,586 (“the ’586 Patent”). This Court has jurisdiction …Page 6 of 47 PageID: 6 Patent No. 8,545,884 and U.S. Patent No. 8,426,586” (the “Notice Letter”). The… Certification That U.S. Patent No. 8,545,884 And U.S. Patent No. 8,426,586 Are Invalid, Unenforceable… US 8,426,586 B2 Page 2 FOREIGN PATENT DOCUMENTS | External link to document | |
| 2019-06-12 | 140 | Order | CONSENT Decree and Judgment Regarding U.S. Patent Nos. 8,545,884 and 9,539,258. Signed by Judge Michael A… 12 November 2020 3:17-cv-07887 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-06-12 | 141 | Order | CONSENT Decree and Judgment Regarding U.S. Patent No. 8,545,884. Signed by Judge Michael A. Shipp on 6/12… 12 November 2020 3:17-cv-07887 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-06-12 | 142 | Order | CONSENT Decree and Judgment Regarding U.S. Patent No. 8,545,884. Signed by Judge Michael A. Shipp on 6/12… 12 November 2020 3:17-cv-07887 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-08-04 | 504 | Order | term “the Asserted Patents” means U.S. Patent Nos. RE 43,431 and 8,426,586, which Sandoz agrees …expiration of an Asserted Patent, including any patent term extension and/or patent term adjustment, and…pediatric exclusivity associated with an Asserted Patent. If Boehringer becomes entitled to any other…maintaining a Paragraph IV Certification to the Asserted Patents in ANDA No. 210703 solely for the purposes of… 12 November 2020 3:17-cv-07887 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
